Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor in acute myocardial infarction patients undergoing emergency PCI: impact on no-reflow
ChiCTR-OPC-17011053Phase 4Recruiting
- Sponsor
- Changhai Hospital
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ticagrelor in myocardial infarction (MI), sponsored by Changhai Hospital. Primary endpoint: Thrombolysis in Myocardial Infarction (TIMI) flow grade. Started May 2017; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-OPC-17011053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17011053.